BIAS NOTICE
Encode may hold positions in covered names, may have current or past compensated relationships, and may be pursuing such relationships. Assume bias. See encodelp.com/disclosure for specifics.
An interview with George Haywood, a well-known investor, where we discuss his perspective on biotech investing. During the interview, we cover some of George’s previous biotech successes, including AVI Biopharma / Sarepta, Martek & Amarin, and his current favorite biotech names, Synaptogenix & Petros.
To listen on Spotify click here
Apple Podcasts here
Podbean here
YouTube here
Treat what you read here as biased. Encode Ideas, LP and its principals may hold positions in any company covered, may have current or past compensated relationships with covered companies, and may be pursuing such relationships. Our analysis is influenced by all of the above - actual positions, current relationships, past relationships, and prospective relationships. Assume errors. Nothing herein is investment advice. See encodelp.com/disclosure for current and past sponsor relationships.
